91 related articles for article (PubMed ID: 9661629)
1. Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.
Wise SD; Nielsen MF; Cryer PE; Rizza RA
J Clin Endocrinol Metab; 1998 Jul; 83(7):2461-9. PubMed ID: 9661629
[TBL] [Abstract][Full Text] [Related]
2. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
5. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
7. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
8. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
Guy DA; Sandoval D; Richardson MA; Tate D; Flakoll PJ; Davis SN
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E178-86. PubMed ID: 15585598
[TBL] [Abstract][Full Text] [Related]
9. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
10. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
Torlone E; Britta M; Rambotti AM; Perriello G; Santeusanio F; Brunetti P; Bolli GB
Diabetes Care; 1993 Oct; 16(10):1347-55. PubMed ID: 8269792
[TBL] [Abstract][Full Text] [Related]
11. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
12. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
13. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
Cuthbertson J; Patterson S; O'Harte FP; Bell PM
Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
[TBL] [Abstract][Full Text] [Related]
14. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
Linfoot P; Bergstrom C; Ipp E
Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
[TBL] [Abstract][Full Text] [Related]
16. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion.
Vigili de Kreutzenberg S; Maifreni L; Lisato G; Riccio A; Trevisan R; Tiengo A; Del Prato S
J Clin Endocrinol Metab; 1990 Apr; 70(4):1023-9. PubMed ID: 2180971
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.
Bajaj M; Pratipanawatr T; Berria R; Pratipanawatr W; Kashyap S; Cusi K; Mandarino L; DeFronzo RA
Diabetes; 2002 Oct; 51(10):3043-8. PubMed ID: 12351445
[TBL] [Abstract][Full Text] [Related]
18. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
19. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
Yki-Järvinen H; Helve E; Sane T; Nurjhan N; Taskinen MR
Am J Physiol; 1989 Jun; 256(6 Pt 1):E732-9. PubMed ID: 2660587
[TBL] [Abstract][Full Text] [Related]
20. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
